The global Gastrointestinal OTC Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Gastrointestinal OTC Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gastrointestinal OTC Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Gastrointestinal OTC Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Gastrointestinal OTC Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bayer
GlaxoSmithKline
Johnson & Johnson
Pfizer
Perrigo
Abbott
C.B. Fleet
Purdue Pharma
Teva Pharmaceutical
Sanofi
Boehringer Ingelheim
Xiuzheng Pharmaceutical Group
China Resources Sanjiu Medical & Pharmaceutical
Harbin Pharmaceutical Group
JZJT
Tongrentang (TRT)

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Capsule
Tablet
Others

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy